Vemurafenib Oral Tablet [Zelboraf]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Vemurafenib is a potent serine/threonine kinase inhibitor and is registered as Zelboraf® for the treatment of metastatic…
Two novel cancer drugs and their companion diagnostics to predict treatment response were given a go-ahead to market in quick…